480 Union Square Drive
New Hope, PA 18938

: 267-744-6400
FX: 267-744-6499
EM: Send Email


Roger Green
President & CEO

Ellen Gordon
Head of Research

On the Web


My Dashboard - Log In

Tools available when logged in
Add Listing Notes Add to RFP List Add as a Favorite
: Pharma Market Research Conference 2015 by Roger Green, Bruce Duncan, Kyle Martin
Published 02/04/2015

Pharma Market Research Conference

Historically, healthcare stakeholders have viewed treatment guidelines as one path to assuring consistent application of high-quality healthcare. In theory, utilizing guidelines guarantees excellent care and a positive cost-benefit profile. In practice, it has never been this simple. Development and enforcement of appropriate guidelines have always presented significant challenges to healthcare systems and insurers. Over the past year, the issues has become more challenging, as an explosion of specialty drug spending has made it impossible for health systems to afford therapies that might prove cost-beneficial in the long run.

Against this background, the application of guidelines has become increasingly controversial and inconsistent. Some professional societies have begun to promulgate cost-sensitive guidelines. At the same time, some insurers claim that they will create or support guidelines that focus even more strongly on cost management in specialty pharmaceuticals. In this session, Dr. Kritzler and Mr. Green will report on a series of on-line bulletin boards conducted with payers nationwide that address changing perspectives and use regarding guidelines, and a study evaluating current utilization trends. Also, they will discuss how developments in HCV and multi-specialty agent regimens in oncology and hematology are reshaping how health plans monitor and manage these categories.

Doing More with Less: Utilizing Small Sample Analytics to Get the Most Out of Your Research Budget
Tuesday, February 3, 2015
9:00 – 10:45 AM
Roger Green, President and CEO, RG+A
Bruce Duncan, Ph.D., Chief Marketing Scientist, RG+A
Kyle Martin, Associate Director, Research, RG+A

Good Guidelines, Bad Guidelines: Why, When, and How Payers Decide to Adopt or Ignore Guidelines in Setting Formularies and Utilization Management Policies

Wednesday, February 4, 2015
3:00 – 3:30pm, TRACK C
Roger Green, President and CEO, RG+A
Robert Kritzler, M.D., Deputy Chief Medical Officer, Care Management, Johns Hopkins HealthCare LLC

Read on the Blog